Ophiomics
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- Undisclosed
Investors
- 1
About Ophiomics
Based in Lisboa, Portugal, and co-founded by osé Pereira Leal and Joana Cardoso Vaz in 2015, Ophiomics operates as a Medtech company developing cancer diagnostic products and services. The clinical-stage Medtech company develops and offers diagnostic products and services that incorporate genomics, artificial intelligence, and bioinformatics to support cancer diagnostics, prognostics, treatment selection, and clinical monitoring. By leveraging the power of genomics and machine learning and by harnessing the potential of AI-driven in vitro diagnostic (IVD) tests, Ophiomics aims to discover biomarkers that address unmet clinical needs. These biomarkers are integrated with clinical variables, ensuring their solutions are accessible and can seamlessly integrate into routine clinical practice. Their product, HepatoPredict, is designed to support the decision of liver transplantation in Hepatocellular carcinoma patients. The other products in the pipeline of Ophiomics include ESODetect for diagnosis and prognosis of Barrett's Esophagus, and HepatoDetect for liquid biopsy for early liver cancer detection in cirrhotic patients.
Who invested in Ophiomics
1 investor across 1 round
See all investors in Ophiomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 18, 2023
Amount
Undisclosed
Investors
Questions about Ophiomics
Who invested in Ophiomics?
Ophiomics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ophiomics raised?
Ophiomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ophiomics last raise money?
Ophiomics's most recent round on record is a Series A, in Jan 2023.
What does Ophiomics do?
Based in Lisboa, Portugal, and co-founded by osé Pereira Leal and Joana Cardoso Vaz in 2015, Ophiomics operates as a Medtech company developing cancer diagnostic products and services.
Where is Ophiomics headquartered?
Ophiomics is headquartered in Lisbon, Portugal.
Which VCs invest in companies like Ophiomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Ophiomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ophiomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.